Trial Profile
A Phase I, Randomised, Open-Label, Three-way Crossover Comparative Pharmacokinetic Study of EMA401 Sodium Salt When Administered Orally in Fed (high fat meal or orange juice only) and Fasted Healthy Adult Males.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Jun 2016
Price :
$35
*
At a glance
- Drugs Olodanrigan (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Spinifex Pharmaceuticals
- 06 Dec 2010 New trial record